FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024496786> ?p ?o ?g. }

• W2024496786 endingPage "437" @default.
• W2024496786 startingPage "430" @default.
• W2024496786 abstract "We hypothesize that differences in the expression of selected tumor suppressor genes, cell surface adhesion molecules, and multidrug resistance glycoproteins could account for some of the reported differences between uterine serous carcinoma (USC) and extrauterine serous carcinomas (ESC), including ovarian and primary peritoneal carcinoma (OSC and PSC, respectively).We studied the expression of the following antigens in 20 USCs, 20 OSCs, and 10 PSCs: p53 and mdm-2 (tumor suppressor genes), CD44 and CD44v6 (cell surface adhesion molecules), and the p-glycoprotein (a multidrug resistance protein recognized by two antibodies, C494 and JSB1). We further studied chemotherapeutic drug resistance by examining reports prepared using the Oncotech Extreme Drug Resistance Assay from 24 of the 50 study patients. Clinical data were obtained from medical record review.USC, OSC, and PSC patients were similar with respect to mean age at diagnosis, mean gravidity, mean parity, personal history of breast cancer, percentage treated with chemotherapy, and survival at 3 and 5 years postdiagnosis. Significant clinical differences included a high prevalence of nulliparity in OSC (P = 0.05), a low prevalence of Caucasian race in USC (P = 0.008), a paucity of stage I patients in OSC and PSC (P = 0.03), a high prevalence of familial breast cancer in OSC (P = 0.06), and superior 2-year survival in OSC (P = 0.02). Seventy-five percent of USCs, 52% of OSCs, and 60% of PSCs expressed p53. Five percent of USCs, 19% of OSCs, and 0% of PSCs expressed mdm-2. Forty percent of USCs, 33% of OSCs, and 10% of PSCs expressed CD44. None of the USCs, OSCs, or PSCs expressed CD44v6. Sixty-one percent of USCs and OSCs and 82% of PSCs expressed C494 while 17% of USCs, 19% of OSCs, and 20% of PSCs expressed JSB1. None of these apparent differences was statistically significant. USC, OSC, and PSCs patients did not demonstrate significant differences with respect to extreme drug resistance. However, the following trends were noted (P = 0.06): more prevalent low drug resistance for cyclophosphamide in OSC compared with USC and more prevalent extreme drug resistance for etoposide in OSC compared with USC.Therefore, despite significant clincial differences, the USCs and ESCs in our series do not differ significantly with respect to the expression of the tumor suppressor genes, cell surface adhesion molecules, and drug resistance proteins studied. It is premature, however, to recommend that USCs and ESCs should be treated identically." @default.
• W2024496786 created "2016-06-24" @default.
• W2024496786 creator A5043064148 @default.
• W2024496786 creator A5050561431 @default.
• W2024496786 creator A5053542215 @default.
• W2024496786 creator A5081926691 @default.
• W2024496786 creator A5084541403 @default.
• W2024496786 date "2000-12-01" @default.
• W2024496786 modified "2023-10-18" @default.
• W2024496786 title "Tumor Suppressor Gene, Cell Surface Adhesion Molecule, and Multidrug Resistance in Müllerian Serous Carcinomas: Clinical Divergence without Immunophenotypic Differences" @default.
• W2024496786 cites W1503726497 @default.
• W2024496786 cites W1591281137 @default.
• W2024496786 cites W1894508692 @default.
• W2024496786 cites W1969447467 @default.
• W2024496786 cites W1978135679 @default.
• W2024496786 cites W1979618464 @default.
• W2024496786 cites W1982908912 @default.
• W2024496786 cites W1987639931 @default.
• W2024496786 cites W1990206463 @default.
• W2024496786 cites W1994743722 @default.
• W2024496786 cites W1999044308 @default.
• W2024496786 cites W1999284510 @default.
• W2024496786 cites W2000865144 @default.
• W2024496786 cites W2010596612 @default.
• W2024496786 cites W2011154946 @default.
• W2024496786 cites W2016294917 @default.
• W2024496786 cites W2034668762 @default.
• W2024496786 cites W2035599508 @default.
• W2024496786 cites W2039677409 @default.
• W2024496786 cites W2040810255 @default.
• W2024496786 cites W2042316019 @default.
• W2024496786 cites W2054872439 @default.
• W2024496786 cites W2060421431 @default.
• W2024496786 cites W2065224605 @default.
• W2024496786 cites W2074736392 @default.
• W2024496786 cites W2085591981 @default.
• W2024496786 cites W2086655228 @default.
• W2024496786 cites W2089586688 @default.
• W2024496786 cites W2091141536 @default.
• W2024496786 cites W2099907467 @default.
• W2024496786 cites W2108069895 @default.
• W2024496786 cites W2117902443 @default.
• W2024496786 cites W2118651430 @default.
• W2024496786 cites W2133058429 @default.
• W2024496786 cites W2136776823 @default.
• W2024496786 cites W2150097377 @default.
• W2024496786 cites W2158079547 @default.
• W2024496786 cites W2168519589 @default.
• W2024496786 cites W2169133611 @default.
• W2024496786 cites W2172106309 @default.
• W2024496786 cites W2296916555 @default.
• W2024496786 cites W2315056059 @default.
• W2024496786 cites W4243612772 @default.
• W2024496786 cites W93096170 @default.
• W2024496786 doi "https://doi.org/10.1006/gyno.2000.6000" @default.
• W2024496786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11104615" @default.
• W2024496786 hasPublicationYear "2000" @default.
• W2024496786 type Work @default.
• W2024496786 sameAs 2024496786 @default.
• W2024496786 citedByCount "10" @default.
• W2024496786 countsByYear W20244967862014 @default.
• W2024496786 countsByYear W20244967862021 @default.
• W2024496786 crossrefType "journal-article" @default.
• W2024496786 hasAuthorship W2024496786A5043064148 @default.
• W2024496786 hasAuthorship W2024496786A5050561431 @default.
• W2024496786 hasAuthorship W2024496786A5053542215 @default.
• W2024496786 hasAuthorship W2024496786A5081926691 @default.
• W2024496786 hasAuthorship W2024496786A5084541403 @default.
• W2024496786 hasConcept C121608353 @default.
• W2024496786 hasConcept C126322002 @default.
• W2024496786 hasConcept C143998085 @default.
• W2024496786 hasConcept C1491633281 @default.
• W2024496786 hasConcept C150173356 @default.
• W2024496786 hasConcept C16224149 @default.
• W2024496786 hasConcept C203014093 @default.
• W2024496786 hasConcept C2776694085 @default.
• W2024496786 hasConcept C2777632260 @default.
• W2024496786 hasConcept C2780427987 @default.
• W2024496786 hasConcept C2780932548 @default.
• W2024496786 hasConcept C502942594 @default.
• W2024496786 hasConcept C54355233 @default.
• W2024496786 hasConcept C71924100 @default.
• W2024496786 hasConcept C86803240 @default.
• W2024496786 hasConceptScore W2024496786C121608353 @default.
• W2024496786 hasConceptScore W2024496786C126322002 @default.
• W2024496786 hasConceptScore W2024496786C143998085 @default.
• W2024496786 hasConceptScore W2024496786C1491633281 @default.
• W2024496786 hasConceptScore W2024496786C150173356 @default.
• W2024496786 hasConceptScore W2024496786C16224149 @default.
• W2024496786 hasConceptScore W2024496786C203014093 @default.
• W2024496786 hasConceptScore W2024496786C2776694085 @default.
• W2024496786 hasConceptScore W2024496786C2777632260 @default.
• W2024496786 hasConceptScore W2024496786C2780427987 @default.
• W2024496786 hasConceptScore W2024496786C2780932548 @default.
• W2024496786 hasConceptScore W2024496786C502942594 @default.
• W2024496786 hasConceptScore W2024496786C54355233 @default.
• W2024496786 hasConceptScore W2024496786C71924100 @default.
• W2024496786 hasConceptScore W2024496786C86803240 @default.

• next